Asie · Marchés régionaux · The Investor

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Publié par The Investor · Corée du Sud il y a 21 h

Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system, strengthenin ...

Lire l'article complet sur The Investor Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.theinvestor.co.kr)

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

À lire aussi

ดอลลาร์อ่อนค่า สอดคล้องบอนด์ยีลด์อ่อนตัว

Big-ticket IPOs have struggled to deliver bumper listing gains. Can Mukesh Ambani backed Reliance Jio buck the trend?

US markets set to open lower as AI stocks slide and oil tops $100

Monetary policy could turn accommodative as AI productivity gains take hold: MAS chief economist

Faster delivery, easier credit fuel South-east Asia e-commerce: survey

Artha Bharat to shift two GIFT City funds to Abu Dhabi over tax hurdles

Samsung Bioepis secures 10-year biosimilar supply deal in Brazil

Partager

À lire aussi

ดอลลาร์อ่อนค่า สอดคล้องบอนด์ยีลด์อ่อนตัว

Big-ticket IPOs have struggled to deliver bumper listing gains. Can Mukesh Ambani backed Reliance Jio buck the trend?

US markets set to open lower as AI stocks slide and oil tops $100

Monetary policy could turn accommodative as AI productivity gains take hold: MAS chief economist

Faster delivery, easier credit fuel South-east Asia e-commerce: survey

Artha Bharat to shift two GIFT City funds to Abu Dhabi over tax hurdles